Norges Bank
OYST

Norges Bank’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Norges Bank’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-25,000
Closed -$611K – 2090
2019
Q4 		$611K Buy
+25,000
New +$439K ﹤0.01% 2045

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KXA
KPCB XIV Associates Menlo Park, California $42.8M AUM 16.52% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Norges Bank's OYST Position: Q1 2020 in Review

Norges Bank sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2020, closing a stake of 25,000 shares — an estimated $611K sold.

Norges Bank first reported a position in OYST in Q4 2019 and held it in 1 quarter. The position peaked at $611K in Q4 2019. 43 funds tracked by Wall St. Rank hold OYST as of Q1 2020.

  • Norges Bank reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Norges Bank sold 25,000 Oyster Point Pharma, Inc. Common Stock shares in Q1 2020, an estimated $611K.
  • Norges Bank first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Norges Bank's Oyster Point Pharma, Inc. Common Stock position peaked at $611K in Q4 2019.
  • 43 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2020.

Based on Norges Bank's 13F filing for Q1 2020, filed 8 May 2020.